Express Scripts Holding Company (ESRX): Playing the Pharmaceutical Distribution Stocks

Page 1 of 2

According to Barron’s, Maxim Group ranked Express Scripts Holding Company (NASDAQ:ESRX) as a buy after its better-than-estimated first quarter earnings results. Since the beginning of the year, Express Scripts has experienced a gain of 10.4%, lower than the S&P 500’s gain of nearly 11%. However, in a longer historical time horizon of 5 years, the company has gained more than 67.5%, leaving the S&P 500 in the dust with only a 12.3% gain. Express Scripts Holding Company (NASDAQ:ESRX) is currently in the portfolio of many famous investment managers, including David Rolfe, Wallace Weitz, Glenn Greenberg and Ken Fisher. Should we get into Express Scripts Holding Company (NASDAQ:ESRX) at its current trading price? Let’s find out.

Huge jump in revenue due to Medco’s acquisition

Express Scripts is considered the biggest player in pharmacy benefit management (PBM), providing various services to wide range of clients including health insurers, managed care organizations, workers’ compensation plans and government health programs. Most of its revenue derived from PBM. In the PBM segment, most if its revenue, $57.76 billion, or 63% of the total 2012 revenue, was generated from network revenue, while home delivery and specialty revenue contributed more than $33 billion in revenue.

In the first quarter of 2013, Express Scripts Holding Company (NASDAQ:ESRX) experienced a huge growth in both its top line and bottom line. Revenue came in at more than $26 billion, more than double the revenue in the first quarter 2012 of only $12.1 billion. The significant increase in its revenue was due to the inclusion of Medco’s operating results. The company’s chairman and CEO commented that a year after Medco’s acquisition the combined company was better than the sum of its parts.

Net income rose as much as 39.2%, from $267.8 million to $373 million. However, EPS experienced a drop by more than 18% to $0.45. The higher net income but lower EPS was due to the significant increase in the total number of outstanding shares, from nearly 490 million shares in the first quarter last year to 832.5 million shares. Express Scripts Holding Company (NASDAQ:ESRX) employed a reasonable amount of debt in its operations. As of March 2013, it had $23.63 billion in total stockholders’ equity, nearly $2 billion in cash, and more than $14.4 billion in both long and short-term debt.

Walgreen Company (NYSE:WAG) and AmerisourceBergen Corp. (NYSE:ABC) might be better picks?

Two years ago, Express Scripts Holding Company (NASDAQ:ESRX) had a dispute on the prescription issue with Walgreen Company (NYSE:WAG). When the company’s exclusive contract with Walgreen was no longer valid, Express Scripts could expand its partnership with other companies, selling its services via various channels. For Walgreen, after the dispute, the stock price experienced a serious free fall. Walgreen lost around $4 billion in revenue because of the dispute. However, Walgreen’s share price has regained its momentum, rising significantly from $32 per share to nearly $49 per share within just more than a year.

Recently, Walgreen and its partner, Alliance Boots, made a big move by signing a 10-year agreement with distributor AmerisourceBergen Corp. (NYSE:ABC) for the distribution of pharmaceuticals to Walgreen’s retail stores. This agreement was reported to be worth as much as $400 billion over 10 years. The partnership between the two will have the huge impact on the pharmaceutical industry because of their market leading positions. Walgreen Company (NYSE:WAG) is the largest U.S. pharmaceutical operator, with nearly 8,400 stores including drugstores, specialty pharmacies, worksite health and wellness centers, and infusion and respiratory services facilities. AmerisourceBergen Corp. (NYSE:ABC) is one of the largest global pharmaceutical services companies, with more than 98% of its revenue coming from pharmaceutical distribution. Interestingly, the largest customer of AmerisourceBergen used to be Medco, representing around 17% of its total revenue in fiscal 2012. Jeff Jonas, a portfolio manager at Gamco Investors commented on the deal:

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!